logo

CVAC(Delisted)

Curevac·NASDAQ
--
--(--)
3.19 / 10
Netural

Comprehensive review: 3.2/10 score signifies concerning fundamentals. Optimistic factors: Revenue-MV and Profit-MV, balanced by issues in Current assets turnover ratio and Fixed assets turnover ratio. Resulting view: defensive.

Fundamental(3.19)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value-0.96
Score2/3
Weight18.98%
1M Return10.38%
Gross profit margin (%)
Value93.85
Score1/3
Weight0.53%
1M Return0.39%
Profit-MV
Value1.80
Score2/3
Weight15.37%
1M Return8.25%
PB-ROE
Value0.02
Score1/3
Weight13.55%
1M Return7.19%
Current assets turnover ratio
Value0.08
Score0/3
Weight-2.83%
1M Return-1.99%
Cash-UP
Value0.45
Score2/3
Weight16.02%
1M Return8.43%
Fixed assets turnover ratio
Value0.28
Score1/3
Weight-1.75%
1M Return-1.27%
Interest coverage ratio (EBIT / Interest expense) (%)
Value-165.96
Score1/3
Weight-1.32%
1M Return-0.91%
Asset-MV
Value-0.52
Score2/3
Weight25.92%
1M Return12.26%
Cash-MV
Value0.42
Score2/3
Weight15.52%
1M Return8.23%
Is CVAC undervalued or overvalued?
  • CVAC scores 3.19/10 on fundamentals and holds a Fair valuation at present. Backed by its 20.61% ROE, 353.51% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 24.01% earnings growth, these metrics solidify its Netural investment rating.